Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Won't run for speaker again
Death ruled accidental
Shares disturbing details
Calif. Sen. Butler sworn in
'I don't really smoke at all'
Daughter talks anxiety issues
Toddler mauled by XL Bully
Faces dog fighting charges
‘Selling personal belongings'
Boy shoots 2, arrested
Judge issues gag order
Diplomatic tensions escalate
To triple small-format stores
Announces Christmas tour
X Social Media sues X
Lay off 500 more employees
Heartburn drug suits settled
Plans to raise prices
Joins Mich. Senate race
Nobel winner presidency bid
Evergrande shares soar
Emergency alert test
Nepal hit by 2 earthquakes
Approves Novavax's vaccine
Abduction suspect found
Ethics violation allegations
Olympics writer dies at 61
Jackpot rises to $1.2B
Hunter pleads not guilty
Shooter's parents on trial
Drug price negotiations begin
Venice bus crash: 21+ killed
Joins Instagram, Threads
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
298,000 results
WISH-TV
5d
Health Spotlight: First FDA-approved drug to slow Alzheimer’s
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...
朝日新聞社15d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...
WNDU12d
Medical Moment: FDA approves first-ever drug to slow Alzheimer’s
(WNDU) - More than six million Americans are living with Alzheimer’s disease; it slowly steals your memories and takes away your mind. There is no cure yet, but now, a newly FDA-approved drug is ...
GEN
4h
Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Morningstar analyst Karen Andersen, CFA, discusses a recent report by her firm about the challenges faced by biopharma with GEN Edge.
Morningstar6d
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition ...
KPLC6d
Health Headlines: FDA approves Alzheimer treatment
CLEVELAND, Ohio (Ivanhoe Newswire) – More than six million Americans are living with Alzheimer’s disease, it slowly steals your memories and takes away your mind. There is no cure, yet, but now, a ...
Journal Record
2h
FDA proposes new regulation of lab tests
The Food and Drug Administration has laid out a proposal to begin regulating laboratory medical tests, a multibillion-dollar ...
The Courier-Journal13d
Delaying Alzheimer's: Norton begins administering new drug to slow dementia progression
Every two weeks, Pam Jeffries settles into an armchair and waits for an infusion of a groundbreaking treatment for her memory loss. The new drug, which was approved by the FDA earlier this year ...
Rapid City Journal
9h
FDA wants to regulate thousands of lab tests that have long skirted oversight
The Food and Drug Administration recently laid out a proposal to begin regulating laboratory medical tests, a ...
komonews4d
New Alzheimer's drug brings hope, slows cognitive decline by 27%
Alisa Carroll (left) says it's imperative a cure is found for Alzheimer's disease. Her mom was diagnosed seven years ago. (Photo: Alisa Carroll) More than 6 million Americans are living with ...
News4Jax5d
First FDA approved drug to slow Alzheimer’s
More than 6 million Americans are living with Alzheimer’s disease. It slowly steals your memories and takes away your mind. There is no cure, yet, but now, a newly FDA-approved drug is helping ...
Business Wire6d
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition “ACI”, or the “Company”), a biopharmaceutical ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices